After the post on sunday, I said I suspected there would be more tolerance studies and I was not wrong there is a study planned for 2022 by Prof R Martin from Switzerland. Here they will stick 12 peptides to red blood cells and infuse them. They plan to target MBP. PLP. MOG, GDPLFS and RASGRP2. I doubt they will deplete the CD4 T cells first….Hands up what you think will happen?
This is what we call a prospective experiment….I set out the issues on Sunday. It should reduce T cell proliferation but wil it STOP and I mean STOP relapsing disease, fewer relapses is a failure.